According to the data provided by the Synapse Database, As of June 13, 2024, there are 52 investigational drugs for the GIPR and GLP-1R target, including 33 indications, 42 R&D institutions involved, with related clinical trials reaching 196, and as many as 1806 patents
GHK-Cu may reduce the sensitivity of hair follicles to DHT without actually lowering hormone levels
Several major randomized controlled trials (RCTs) have confirmed the efficacy and safety of GLP-1RAs in adults with diabetes 17 and obesity 18 , and more recently in child and adolescent populations living with obesity 19,20
Cycle Length Standard IGF-1 LR3 cycles last 46 weeks to prevent desensitization
It may be considered for eligible patients seeking provider-guided support for energy, metabolism, and overall wellness